WestEnd Advisors’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
RCMNY
WestEnd Advisors's VTRS Position: Q2 2026 in Review
WestEnd Advisors increased its Viatris (VTRS) stake by 13% in Q2 2026, buying an estimated $62 and bringing the position to 35 shares worth $556. The position accounts for ﹤0.01% of the portfolio, ranked #334.
WestEnd Advisors first reported a position in VTRS in Q4 2021 and has held it in 16 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.
- WestEnd Advisors held 35 shares of Viatris worth $556 as of Q2 2026.
- WestEnd Advisors bought 4 Viatris shares in Q2 2026, an estimated $62.
- Viatris made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #334 holding.
- WestEnd Advisors first reported a position in Viatris in Q4 2021 and has held it in 16 quarters since.
- 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.
Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.